For: | Kawai H, Nomoto M, Suda T, Kamimura K, Tsuchiya A, Tamura Y, Yano M, Takamura M, Igarashi M, Wakai T, Yamagiwa S, Matsuda Y, Ohkoshi S, Kurosaki I, Shirai Y, Okada M, Aoyagi Y. Multicentric occurrence of hepatocellular carcinoma with nonalcoholic steatohepatitis. World J Hepatol 2011; 3(1): 15-23 [PMID: 21307983 DOI: 10.4254/wjh.v3.i1.15] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v3/i1/15.htm |
Number | Citing Articles |
1 |
Ester Vanni, Elisabetta Bugianesi. Obesity and Liver Cancer. Clinics in Liver Disease 2014; 18(1): 191 doi: 10.1016/j.cld.2013.09.001
|
2 |
Sahil Mittal, Donna L. White, Fasiha Kanwal, Norman Sussman, Hashem B. El-Serag. Nonalcoholic Fatty Liver Disease (NAFLD) and Hepatocellular Carcinoma: How Common?. Current Hepatology Reports 2015; 14(2): 87 doi: 10.1007/s11901-015-0259-5
|
3 |
Masahiro Ogawa, Atsunori Tsuchiya, Takayuki Watanabe, Toru Setsu, Naruhiro Kimura, Masato Matsuda, Yoshiki Hoshiyama, Hiroaki Saito, Tsutomu Kanazawa, Motoi Shiotani, Tatsuhiko Sato, Takuya Yagi, Koji Igarashi, Norihiko Yoshimura, Masaaki Takamura, Hidefumi Aoyama, Shuji Terai. Screening and follow‐up of chronic liver diseases with understanding their etiology in clinics and hospitals. JGH Open 2020; 4(5): 827 doi: 10.1002/jgh3.12406
|
4 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_164-1
|
5 |
Etsuko Hashimoto, Katsutoshi Tokushige. Hepatocellular carcinoma in non‐alcoholic steatohepatitis: Growing evidence of an epidemic?. Hepatology Research 2012; 42(1): 1 doi: 10.1111/j.1872-034X.2011.00872.x
|
6 |
Donna L. White, Fasiha Kanwal, Hashem B. El–Serag. Association Between Nonalcoholic Fatty Liver Disease and Risk for Hepatocellular Cancer, Based on Systematic Review. Clinical Gastroenterology and Hepatology 2012; 10(12): 1342 doi: 10.1016/j.cgh.2012.10.001
|
7 |
Carmine Finelli, Giovanni Tarantino. Should visceral fat, strictly linked to hepatic steatosis, be depleted to improve survival?. Hepatology International 2013; 7(2): 413 doi: 10.1007/s12072-012-9406-z
|
8 |
|
9 |
Ester Vanni, Lavinia Mezzabotta, Elisabetta Bugianesi. NAFLD and Hepatocellular Carcinoma: How Big a Problem is This Really?. Current Hepatology Reports 2014; 13(2): 113 doi: 10.1007/s11901-014-0225-7
|
10 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 2931 doi: 10.1007/978-3-319-26956-6_164
|
11 |
Megumi Inoue, Junya Oribe, Masataka Seike, Takayuki Masaki, Mizuki Endo, Masanori Tokoro, Mie Yoshihara, Koichi Honda, Rie Shin, Katsunari Abe, Nobuyuki Abe, Hironobu Yoshimatsu. High alanine aminotransferase level as a predictor for the incidence of macrovascular disease in type 2 diabetic patients with fatty liver disease. Hepatology International 2013; 7(2): 555 doi: 10.1007/s12072-012-9366-3
|